On Friday, our CEO tells us, "...I'm not sure I want to necessarily play in a segment like pharmaceuticals; we don't have much presence there. So why should we go play there? Let's play in these tremendously large markets we have access (to) today. "
Today at the PMT Town Hall, we learn all about the new breakthrough initiative in pharmaceuticals.
Even building software for pharma automation is expensive. HON tried for a decade and divested the business because they couldn't make it sufficiently profitable.
They want to play in pharma until they realize what the regs are and how much it'll cost to get our facilities up to required specs. It costs $$$$ to play in pharma. Dolts messed up the Sigma-Aldrich acquisition and are freaking out now in Germany cause the FDA is coming to audit.
Hahahaha he learned how to lie from his boyfriend, D. Cote.
Hey ya gotta stay connected LOL